Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

Revolution Medicines, Inc. (RVMD) Tops Q2 EPS by 3c

August 9, 2022 5:01 PM EDT

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($0.82), $0.03 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $7.02 million.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

... More